Financial Analysis

Samsung Life (032830.KS) Q1 2026: ₩18T Capital Surge as Profit Jumps 89%

A bond-revaluation tailwind lifted equity by nearly a third in a single quarter, even as core insurance margins held steady.

KB Financial Group (105560.KS) Q1 2026: Net Profit Jumps 12.8% to ₩1.92T as ₩7.5T Capital Reserve Transfer Loads Buyback Arsenal

SK Square's Q1 Profit Hits Record ₩8.3T, Lifts Holdco to KOSPI No. 3

SK Square — the SK Group investment arm spun off from SK Telecom in 2021 and now SK Hynix's largest single shareholder — said on Thursday that its first-quarter oper

Kakao Corp. (035720.KS) — FY2025 Financial Analysis

Kia (000270.KS) — Q1 FY2026 Financial Analysis

Shinhan Financial Group (055550.KS) — FY2025 Financial Analysis

SK Innovation Swings to ₩2.16 Trillion Q1 Profit as Iran War Lifts Refining Margins

SK Innovation (096770.KS) swung to a ₩2.16T Q1 operating profit from a ₩30.7B loss, as a ₩780B inventory gain at SK Energy followed the post-Iran-war oil spike.

LG Chem (051910.KS) — FY2025 Financial Analysis

Samsung C&T Corporation (028260.KS) — FY2025 Financial Analysis

KakaoBank (323410.KS) Q1 Net Hits Record ₩187.3B on Superbank IPO

KakaoBank's Q1 net jumped 36.3% to a record ₩187.3 billion ($128.4M), but a one-off ₩93.3B Superbank IPO gain masked a 13.9% drop in core operating profit.

Ssangyong C&E Co., Ltd. (003410, Delisted from KOSPI) — FY2025 Financial Analysis

Celltrion (068270.KS) Q1 Profit Doubles on Biosimilar Surge

Celltrion's Q1 operating profit more than doubled to 321.9 billion won as biosimilar sales drove revenue up 28% to a record 1.145 trillion won.